Patents Assigned to Vitreoretinal Development, Inc.
-
Patent number: 5047009Abstract: Ocular perfusion during intraocular surgery of the anterior or posterior ocular cavity is optimized through the method of using a gas pump having a discernible and controllable output pressure to pressurize a reservoir of liquid infusate, which is supplied under pressure to a surgical infusion instrument for perfusion of the selected ocular chamber (Gas Forced Liquid Infusion, GFLI). The infusate selection and the infusate pressure can be controlled with a high degree of accuracy and both can be rapidly varied by audible command. Preferentially a human sensible indication of pressure is constantly available at the gas pump.Type: GrantFiled: February 12, 1990Date of Patent: September 10, 1991Assignee: Vitreoretinal Development, Inc.Inventors: Robert E. Morris, Clark D. Witherspoon, William E. Goggans, Jr.
-
Patent number: 5032111Abstract: Ocular perfusion during intraocular surgery of the anterior or posterior ocular cavity is optimized through the method of using a gas pump having a discernible and controllable output pressure to pressurize a reservoir of liquid infusate, which is supplied under pressure to a surgical infusion instrument for perfusion of the selected ocular chamber (Gas Forced Liquid Infusion, GFLI). The infusate selection and the infusate pressure can be controlled with a high degree of accuracy and both can be rapidly varied by audible command. Preferentially a human sensible indication of pressure is constantly available at the gas pump.Type: GrantFiled: November 20, 1989Date of Patent: July 16, 1991Assignee: Vitreoretinal Development, Inc.Inventors: Robert E. Morris, Clark D. Witherspoon, William E. Goggans, Jr.
-
Patent number: 5021057Abstract: An instrument to be used during ocular surgery for the rapid closure of anterior segment openings and the control of expulsive choroidal hemorrhage and the resulting damage caused by this complication. The instrument is to be positioned over the anterior ocular surface of the eye at the first indication of hemorrhage or "posterior pressure". One or more dimples located on the upper surface of the instrument allows the insertion of a elongated member for holding the instrument in place while maintaining the intraocular pressure. An opening is also present which allows a surgeon to insert sutures into the underlying eye while the instrument is in place and also aids in the movement of the instrument about the anterior ocular surface of the eye by insertion of a probe or forceps. The instrument is transparent, allowing the surgeon to visually monitor the intraocular events.Type: GrantFiled: June 28, 1990Date of Patent: June 4, 1991Assignee: Vitreoretinal Development, Inc.Inventor: James B. Byrne, Jr.
-
Patent number: 4900301Abstract: Ocular perfusion during intraocular surgery of the anterior or posterior ocular cavity is optimized through the method of using a gas pump having a discernible and controllable output pressure to pressurize a reservoir of liquid infusate, which is supplied under pressure to a surgical infusion instrument for perfusion of the selected ocular chamber (Gas Forced Liquid Infusion, GFLI). The infusate selection and the infusate pressure can be controlled with a high degree of accuracy and both can be rapidly varied by audible command. Preferentially a human sensible indication of pressure is constantly available at the gas pump.Type: GrantFiled: May 23, 1988Date of Patent: February 13, 1990Assignee: Vitreoretinal Development, Inc.Inventors: Robert E. Morris, Clark D. Witherspoon, William E. Goggans, Jr.
-
Patent number: 4813927Abstract: Apparatus for us in intraocular surgical procedures utilizes a plurality of flexible conduits and a control valve to selectively supply an infusion cannula with either fluid or air. The air and fluid are pressurized for infusion by a continuous infusion air pump and supplied to the valve by parallel lengths of flexible tubing. The apparatus may be used to monitor and control the infusion pressure or to switch the infusion agent in a minimal time.Type: GrantFiled: September 22, 1987Date of Patent: March 21, 1989Assignee: Vitreoretinal Development, Inc.Inventors: Robert E. Morris, Clark D. Witherspoon, William E. Goggans, Jr.